// App-Quantinova.ai

P684 : A first clinical trial of a novel narrow spectrum kinase inhibitor TOP1288 in patients with ulcerative colitis

Researchers

Presenter

  • M. Taylor

Principal Investigators

  • A. Duggal

  • A. Rowley

  • M. Foster

  • S. Sirohi

  • Y. Solanke

  • C. Walshe

  • S. Webber

  • S. Travis

  • P. Irving

Medical Centers

  • Topivert Pharma, London, United Kingdom

  • Oxford University Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom

  • Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Mesalamine

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved